Ftse Mib
33.692,60
-0,28%
DAX
19.863,63
-0,68%
S&P 500
5.910,55
0,74%
NASDAQ
19.516,79
0,74%
Bitcoin
96.750,16
-0,73%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mainz BioMed NV (MYNZ) Mainz BioMed NV (MYNZ) Notizie

Mainz BioMed NV

MYNZ
5,7147
0,9447 (19,81%)
Ultimo aggiornamento: 16:46:03
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202414:01GLOBEMainz Biomed Forms Agreement with Quest Diagnostics to..
16/12/202423:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/12/202423:00GLOBEMainz Biomed Announces Closing of $8.0 Million Follow-On..
16/12/202414:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/12/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
13/12/202402:00GLOBEMainz Biomed Announces Pricing of $8.0 Million Follow-On..
11/12/202415:22IHNWSilexion Is Addressing the MOST COMMON Human Cancer Gene..
11/12/202414:00EDGAR2Form F-1/A - Registration statement for certain foreign..
09/12/202423:11EDGAR2Form F-1/A - Registration statement for certain foreign..
09/12/202415:16EDGAR2Form F-1/A - Registration statement for certain foreign..
29/11/202414:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202414:45GLOBEMainz Biomed Announces Stock Split
15/11/202423:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202415:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202415:00GLOBEMainz Biomed and Thermo Fisher Scientific Sign a..
05/11/202414:00EDGAR2Form F-1 - Registration statement for certain foreign..
21/10/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/10/202414:01GLOBEMainz Biomed Reports Mid-Year 2024 Financial Results and..
18/10/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/10/202423:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/10/202414:01GLOBEMainz Biomed Reports Increased Demand for Enhanced..
03/10/202423:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/10/202414:01GLOBEMainz Biomed Publishes CEO Statement; CEO Guido Baechler..
18/9/202414:01GLOBEMainz Biomed Announces Petra Smeltzer Starke to Join Company..
04/9/202410:01GLOBEMainz Biomed Partners with Liquid Biosciences to Leverage..
25/7/202414:01GLOBEMainz Biomed Launches Enhanced ColoAlert with Cutting-Edge..
09/7/202415:30APSMicro Cap Bid Up Following FDA Submission Announcement
09/7/202409:01GLOBEMainz Biomed Announces Submission for FDA Breakthrough..
02/7/202414:01GLOBEMainz Biomed Provides Half Year 2024 Corporate Update
03/6/202414:01GLOBEMainz Biomed Presented Industry Leading Results of its..
31/5/202423:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202423:01GLOBEMainz Biomed Reports Results of 2024 Annual General Meeting
28/5/202414:01GLOBEMainz Biomed to Present New Pooled Colorectal Cancer..
20/5/202414:01GLOBEMainz Biomed Awarded Poster of Distinction at Digestive..
07/5/202414:01GLOBEMainz Biomed to Present Results of Colorectal Cancer..
25/4/202415:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
09/4/202414:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
19/3/202413:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
18/3/202413:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
12/3/202413:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
05/3/202414:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
27/2/202414:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
22/2/202414:01GLOBEMainz Biomed Announces Distribution Partnership with..
21/2/202414:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
06/2/202414:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
11/1/202414:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
09/1/202414:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
Apertura: 5,24 Min: 5,19 Max: 6,26
Chiusura: 4,77

La tua Cronologia

NASDAQ
MYNZ
Mainz BioMed NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network